Sirolimus Is Effective in Relapsed/Refractory Autoimmune Cytopenias: Results of a Prospective Multi-Institutional Trial

Blood - United States
doi 10.1182/blood-2015-07-657981
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Response to Mercaptopurine for Refractory Autoimmune Cytopenias in Children

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2009English

Multicenter Clinical Trial of Bortezomib in Relapsed/Refractory Waldenstrom's Macroglobulinemia: Results of WMCTG Trial 03-248

Clinical Cancer Research
Cancer ResearchOncology
2007English

Use of Rituximab for Refractory Cytopenias Associated With Autoimmune Lymphoproliferative Syndrome (ALPS)

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2009English

Autoimmune Cytopenias in Chronic Lymphocytic Leukemia

American Journal of Hematology
Hematology
2014English

Infliximab Therapy for Refractory Uveitis: 2-Year Results of a Prospective Trial

Archives of Ophthalmology
2009English

Autoimmune Cytopenias in Common Variable Immunodeficiency

Frontiers in Immunology
AllergyImmunology
2012English

Interim Results of OPAL, a Study of Tosedostat in Elderly Relapsed/Refractory AML.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Thalidomide Versus Dexamethasone for the Treatment of Relapsed and/or Refractory Multiple Myeloma: Results From OPTIMUM, a Randomized Trial

Haematologica
Hematology
2011English

A Prospective, Open-Label Trial of Sirolimus in the Treatment of Focal Segmental Glomerulosclerosis

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy